Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Should we feel free to use loco-regional anesthesia in multiple sclerosis?
[Pathogenesis of neuromyelitis optica].
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
[Of worms and men--Administration of helminth products as an innovative approach to treatment of autoimmune diseases].
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
Self-intermittent catheterization in multiple sclerosis.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.
The incidence and prevalence of multiple sclerosis in nova scotia, Canada.
Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy.
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus.
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene.
The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
Patients' perspectives on quality of mental health care for people with MS.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
Functional connectivity analyses using emulated and conventional resting state data: Parts vs. the whole story.
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Pages
« first
‹ previous
…
350
351
352
353
354
355
356
357
358
…
next ›
last »